-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Thermo Fisher Scientific, Lowers Price Target to $637

Benzinga·04/24/2025 18:34:10
Listen to the news
RBC Capital analyst Conor McNamara maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and lowers the price target from $651 to $637.